Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways
Milad Ashrafizadeh, Ali Zarrabi, Sedigheh Saberifar, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 110-110
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 133
Roles of circadian clocks in cancer pathogenesis and treatment
Yool Lee
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 10, pp. 1529-1538
Open Access | Times Cited: 105
Plant Foods and Their Bioactives as Dietary Enhancers for Colon Cancer Treatment with 5-Fluorouracil
Zhongming Yang, Carlos L. Céspedes, Zhongguo Yang, et al.
Food Reviews International (2025), pp. 1-50
Closed Access | Times Cited: 4
Circadian Rhythms, Disease and Chronotherapy
Yool Lee, Jeffrey Field, Amita Sehgal
Journal of Biological Rhythms (2021) Vol. 36, Iss. 6, pp. 503-531
Open Access | Times Cited: 86
lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer
Qingzhu Yang, Kai Li, Xuemei Huang, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 19, pp. 974-985
Open Access | Times Cited: 80
Nobiletin Protects against Systemic Inflammation-Stimulated Memory Impairment via MAPK and NF-κB Signaling Pathways
Guoyuan Qi, Yashi Mi, Rong Fan, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 18, pp. 5122-5134
Closed Access | Times Cited: 78
Role of Oxidative Stress and Nrf2/KEAP1 Signaling in Colorectal Cancer: Mechanisms and Therapeutic Perspectives with Phytochemicals
Da-Young Lee, Moon-Young Song, Eun‐Hee Kim
Antioxidants (2021) Vol. 10, Iss. 5, pp. 743-743
Open Access | Times Cited: 64
Clocking cancer: the circadian clock as a target in cancer therapy
Francesca Battaglin, Priscilla Chan, Yuanzhong Pan, et al.
Oncogene (2021) Vol. 40, Iss. 18, pp. 3187-3200
Open Access | Times Cited: 63
ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
Eunju Kim, Yoon-Jin Kim, Zhiwei Ji, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 47
Nobiletin as an inducer of programmed cell death in cancer: a review
Jun Huang, Zaoshang Chang, Quzhe Lu, et al.
APOPTOSIS (2022) Vol. 27, Iss. 5-6, pp. 297-310
Closed Access | Times Cited: 42
Nobiletin Induces Ferroptosis in Human Skin Melanoma Cells Through the GSK3β-Mediated Keap1/Nrf2/HO-1 Signalling Pathway
Senling Feng, Yongheng Zhou, Hongliang Huang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 37
Next-Generation Hydrogels as Biomaterials for Biomedical Applications: Exploring the Role of Curcumin
Vijay Sagar Madamsetty, Maryam Vazifehdoost, Samira Hossaini Alhashemi, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 8960-8976
Open Access | Times Cited: 25
Tumor microenvironment remodeling in oral cancer: Application of plant derived-natural products and nanomaterials
Hendrik Setia Budi, Bagher Farhood
Environmental Research (2023) Vol. 233, pp. 116432-116432
Closed Access | Times Cited: 22
Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications
Yongkang Cheng, Sansan Feng, Chu-Qiao Sheng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
β-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway
Mingming Deng, Bofang Liu, Huicong Song, et al.
Phytomedicine (2020) Vol. 69, pp. 153184-153184
Closed Access | Times Cited: 59
Emerging Nanopharmaceuticals and Nanonutraceuticals in Cancer Management
Lavinia Salama, Elizabeth Pastor, Tyler Stone, et al.
Biomedicines (2020) Vol. 8, Iss. 9, pp. 347-347
Open Access | Times Cited: 50
Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics
Ranjith Kumavath, Sayan Paul, Honey Pavithran, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1275-1275
Open Access | Times Cited: 46
Nobiletin as a chemopreventive natural product against cancer, a comprehensive review
Yunyi Chen, Jiaojiao Liang, Deng-Liang Wang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 23, pp. 6309-6329
Closed Access | Times Cited: 36
Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
Jian Huang, Biyun Lin, Benyi Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 31
Apigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms
Masoud Moslehi, Sepideh Rezaei, Pourya Talebzadeh, et al.
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 1, pp. 3-18
Closed Access | Times Cited: 30
Xanthohumol: An underestimated, while potent and promising chemotherapeutic agent in cancer treatment
Shadi Vesaghhamedani, Farnoosh Ebrahimzadeh, Elnaz Najafi, et al.
Progress in Biophysics and Molecular Biology (2022) Vol. 172, pp. 3-14
Closed Access | Times Cited: 27
Targeting anticancer immunity in oral cancer: Drugs, products, and nanoparticles
Liling Qin, Jianan Wu
Environmental Research (2023) Vol. 239, pp. 116751-116751
Closed Access | Times Cited: 20
Learning from circadian rhythm to transform cancer prevention, prognosis, and survivorship care
Xiaoyan Zhu, Geraldine Maier, Satchidananda Panda
Trends in cancer (2023) Vol. 10, Iss. 3, pp. 196-207
Open Access | Times Cited: 18
Nobiletin inhibits de novo FA synthesis to alleviate gastric cancer progression by regulating endoplasmic reticulum stress
Menglin Chen, Ruijuan Zhang, Yaling Chen, et al.
Phytomedicine (2023) Vol. 116, pp. 154902-154902
Closed Access | Times Cited: 17
Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds
Neeraj Choudhary, Sweta Bawari, Jack T. Burcher, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3980-3980
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top